Aharon Schwartz, Director at Protalix BioTherapeutics, Inc. (PLX), bought 110,000 shares at $1.42 ($156K) on 2023-01-03, disclosed to the SEC on 2023-01-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| FOMX | BUY | 2018-12-06 | $438K | — | Filing → |